In a phase II study of BKM120 in recurrent GBM, patients with radiologic progression and activation of PI3K/Akt pathway including PIK3CA mutations, PTEN loss and increased phosphorylation of Akt were recruited (NCT01339052). Here, PIK3CA is linked to glioblastoma.